1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRAF -mutated advanced colorectal cancer: A rapidly changing therapeutic landscape
    Review

    Ciombor, K. K.; Strickler, J. H.; Bekaii-Saab, T. S.; Yaeger, R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Management of advanced human epidermal growth factor receptor 2–positive breast cancer and brain metastases: ASCO guideline update
    Guidelines

    Ramakrishna, N.; Anders, C. K.; Lin, N. U.; Morikawa, A.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Franzoi, M. A. B.; Kirshner, J. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Systemic therapy for advanced human epidermal growth factor receptor 2–positive breast cancer: ASCO guideline update
    Guidelines

    Giordano, S. H.; Franzoi, M. A. B.; Temin, S.; Anders, C. K.; Chandarlapaty, S.; Crews, J. R.; Kirshner, J. J.; Krop, I. E.; Lin, N. U.; Morikawa, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association of low and intermediate combined positive scores with outcomes of treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma: Secondary analysis of keynote 048
    Research Letter

    Yu, Y.; Zakeri, K.; Sherman, E. J.; Lee, N. Y.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy
    Journal Article

    Garcia-Aguilar, J.; Patil, S.; Gollub, M. J.; Kim, J. K.; Yuval, J. B.; Thompson, H. M.; Verheij, F. S.; Omer, D. M.; Lee, M.; Dunne, R. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Plant-based and ketogenic diets as diverging paths to address cancer: A review
    Review

    Shah, U. A.; Iyengar, N. M.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels
    Journal Article

    Ricciuti, B.; Wang, X.; Alessi, J. V.; Rizvi, H.; Mahadevan, N. R.; Li, Y. Y.; Polio, A.; Lindsay, J.; Umeton, R.; Sinha, R.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Keeping meta-analyses fresh
    Editorial

    Berlin, J. A.; Rubenfeld, G. D.; O'Cearbhaill, R. E.; Shah, A. S.; Fihn, S. D.
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Outcomes and molecular features of brain metastasis in gastroesophageal adenocarcinoma
    Journal Article

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Feder, L.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
    Journal Article

    Adra, N.; Vaughn, D. J.; Einhorn, L. H.; Hanna, N. H.; Funt, S. A.; Rosales, M.; Arozullah, A.; Feldman, D. R.
    Investigational New Drugs (2022)

    Fulltext@MSK | Save